Market by Product Type, Gender, Application, End-user, and Country Outlook | Forecast 2023-2030
Triton’s report displays that the botulinum toxin market in the Middle East and Africa is anticipated to witness a CAGR of 10.03% during the forecasting years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries evaluated in the region comprise:
•
United Arab Emirates
•
Saudi Arabia
•
Israel
•
South Africa
•
Rest of Middle East & Africa
An
increasing multitude of medical professionals have commenced utilizing
botulinum toxin to address an extensive array of medical ailments in the region.
Its application extends to treating various dental afflictions such as bruxism,
elevated lip lines, interdental gaps, and issues concerning the
temporomandibular joint. The market’s appeal is on the rise, propelled by
various initiatives, including brief courses centered around non-cosmetic
applications and contraindications.
Saudi Arabia holds the highest
share in the given region’s market. In recent years,
there has been a rise in the demand for non-surgical cosmetic treatments.
According to estimates, Saudi Arabia holds a significant position among the top
25 countries globally with the highest rates of cosmetic procedures. Several
factors have contributed to the growth of the botulinum toxin market, including
increased accessibility to aesthetic centers, a rise in consumer purchasing
power, and a shift in consumer perception toward healthy aging, wellness, and
beauty. These factors collectively contribute to the studied market’s
progression.
Cosmetic
surgery ranks among the top five medical tourism treatments, contributing to
the increasing demand for cosmetic procedures in the UAE. The aesthetics sector
is significant in driving medical tourism, fueled by a growing number of
locally established clinics. These factors, along with a surge in demand for
cosmetic treatments among the younger demographic, further open avenues for the
botulinum toxin market.
While
women constitute the majority of patients in aesthetic medicine, recent studies
indicate a growing trend of men opting for cosmetic procedures. In 2020,
approximately 8% of all cosmetic surgeries were performed on men, as reported
by the American Society of Plastic Surgeons (ASPS). Although this increase
might not be exponential due to its modest proportion compared to female
patients, it does reveal a consistent upward trajectory. Men appear
particularly inclined towards minimally invasive cosmetic treatments with
minimal recovery time.
The market’s growth is
determined by gender, product type, application, and end-user.
The gender segment includes male and female.
The major companies in the market
consist of Daewoong Pharmaceutical Co Ltd, Galderma SA, Ipsen Pharma, Hugel Inc,
Candela Medical Corporation, and Merz Pharma GmbH & Co KGaA.
Merz
Pharma GmbH & Co KGaA is a privately-owned
pharmaceutical firm focusing on exploring, advancing, and disseminating
inventive products in aesthetic medicine and movement disorders. The company
encompasses various enterprises: Merz Aesthetics, Merz Therapeutics, Merz
Consumer Care, Merz Real Estate, and Merz Financial Investments. Its product
line includes botulinum neurotoxin, which activates the muscular system, blocking
an overactive muscle. Merz’s operations span multiple regions, including the
Middle East and Africa.
Key deliverables of the report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the botulinum toxin market revenue growth in the Middle East and
Africa and its influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the Middle East and Africa botulinum toxin market’s growth
during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE BOTULINUM TOXIN MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHTS
2.2.1. GROWING
DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
2.2.2. SURGE
IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS
AND
GEN-Z
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. PRODUCT
LAUNCHES
2.5.2. COLLABORATIONS
2.5.3. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.4. ACQUISITIONS
2.6. MARKET
DRIVERS
2.6.1. SURGE
IN DEMAND FOR AESTHETIC PROCEDURES
2.6.2. RISE
IN GERIATRIC POPULATION
2.7. MARKET
CHALLENGES
2.7.1. LIMITED
REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.7.2. ADVERSE
EFFECTS OF BOTULINUM TOXIN
2.7.3. EMERGING
PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE
2.8. MARKET
OPPORTUNITIES
2.8.1. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8.2. RISING
MEDICAL TOURISM
2.9. ANALYST
PERSPECTIVE
3. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE
3.1. TYPE A
BOTULINUM TOXIN
3.2. TYPE B
BOTULINUM TOXIN
4. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER
4.1. WOMEN
4.2. MEN
5. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION
5.1. AESTHETIC
5.1.1. CROW’S
FEET
5.1.2. FOREHEAD
LINES
5.1.3. FROWN
LINES/GLABELLAR
5.1.4. SQUARE
JAW/MASSETER
5.1.5. OTHER
AESTHETIC APPLICATIONS
5.2. MEDICAL
5.2.1. CHRONIC
MIGRAINE
5.2.2. MUSCLE
SPASM
5.2.3. OVERACTIVE
BLADDER
5.2.4. HYPERHIDROSIS
5.2.5. OTHER
MEDICAL APPLICATIONS
6. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER
6.1. SPECIALTY
AND DERMATOLOGY CLINICS
6.2. HOSPITALS
AND CLINICS
6.3. OTHER
END-USERS
7. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – BY COUNTRY OUTLOOK
7.1. MIDDLE
EAST AND AFRICA
7.1.1. MARKET
BY PRODUCT TYPE
7.1.2. MARKET
BY GENDER
7.1.3. MARKET
BY APPLICATION
7.1.3.1. MARKET
BY AESTHETIC
7.1.3.2. MARKET
BY MEDICAL
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
ARAB EMIRATES
7.1.5.1.1. UNITED
ARAB EMIRATES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.2. SAUDI
ARABIA
7.1.5.2.1. SAUDI
ARABIA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.3. ISRAEL
7.1.5.3.1. ISRAEL
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.4. SOUTH
AFRICA
7.1.5.4.1. SOUTH
AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.5. REST
OF MIDDLE EAST & AFRICA
7.1.5.5.1. REST
OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. ABBVIE
INC
8.1.1. OVERVIEW
8.1.2. PRODUCT
PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. EVOLUS
INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. MEDYTOX
INC
8.3.1. OVERVIEW
8.3.2. PRODUCT
PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. LANZHOU
INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT
PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. DAEWOONG
PHARMACEUTICAL CO LTD
8.5.1. OVERVIEW
8.5.2. PRODUCT
PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. GALDERMA
SA
8.6.1. OVERVIEW
8.6.2. PRODUCT
PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY CHALLENGES
8.7. IPSEN
PHARMA
8.7.1. OVERVIEW
8.7.2. PRODUCT
PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. HUGEL
INC
8.8.1. OVERVIEW
8.8.2. PRODUCT
PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. CANDELA
MEDICAL CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. MERZ
PHARMA GMBH & CO KGAA
8.10.1. OVERVIEW
8.10.2. PRODUCT
PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. REVANCE
THERAPEUTICS INC
8.11.1. OVERVIEW
8.11.2. PRODUCT
PORTFOLIO
8.12. US
WORLDMEDS LLC
8.12.1. OVERVIEW
8.12.2. PRODUCT
PORTFOLIO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: MIDDLE EAST AND
AFRICA REGULATORY FRAMEWORK FOR BOTULINUM TOXIN
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF
COLLABORATIONS
TABLE 5: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLE OF
COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 8: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 14: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 2: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $
MILLION)
FIGURE 3: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $
MILLION)
FIGURE 4: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY GENDER, 2022 & 2030 (IN %)
FIGURE 5: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2022 & 2030 (IN %)
FIGURE 8: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2022 & 2030 (IN %)
FIGURE 10: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $
MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $
MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2022 & 2030 (IN %)
FIGURE 17: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $
MILLION)
FIGURE 22: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 23: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030
(IN $ MILLION)
FIGURE 24: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $
MILLION)
FIGURE 25: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 26: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 27: UNITED ARAB
EMIRATES BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: SAUDI ARABIA
BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: ISRAEL BOTULINUM
TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: SOUTH AFRICA
BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: REST OF MIDDLE EAST
& AFRICA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)